A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients

By                      

Oncology Reports, Vol. 30, Iss. 3, 2013-01 ,pp. : 1094-1100

Spandidos Publications

Access to resources Recommend Favorite

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination

By Romero Pedro   Cerottini Jean-Charles   Speiser Daniel  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 3, 2004-03 ,pp. : 249-255

Springer Publishing Company

Access to resources Recommend Favorite

Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer

By                  

International Journal of Oncology, Vol. 44, Iss. 3, 2014-01 ,pp. : 662-668

Spandidos Publications

Access to resources Recommend Favorite

Phase I clinical trial of vaccination with LY6K-derived peptide in patients with advanced gastric cancer

By Ishikawa Hajime   Imano Motohiro   Shiraishi Osamu   Yasuda Atsushi   Peng Ying-Feng   Shinkai Masayuki   Yasuda Takushi   Imamoto Haruhiko   Shiozaki Hitoshi  

Gastric Cancer, Vol. 17, Iss. 1, 2014-01 ,pp. : 173-180

Springer Publishing Company

Access to resources Recommend Favorite

Vaccination with p53-peptide–pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study

By Svane Inge   Pedersen Anders   Johnsen Hans   Nielsen Dorte   Kamby Claus   Gaarsdal Eva   Nikolajsen Kirsten   Buus Søren   Claesson Mogens  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 633-641

Springer Publishing Company

Access to resources Recommend Favorite